EXTH-81. ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST TREATMENT REFRACTORY MEDULLOBLASTOMA

Authors: David Bakhshinyan, Yujin Suk, Laura Kuhlman, Ashley Adile, Vladimir Ignatchenko, William Gwynne, Stefan Custers, Andrew Macklin, Chitra Venugopal, Thomas Kislinger, Sheila Singh

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.879

Source: Full article


Abstract

Abstract